X4 Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XFOR and other ETFs, options, and stocks.

About XFOR

X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor.

CEO

Paula S. Ragan

CEOPaula S. Ragan

Employees

Employees93

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2010

Founded2010

Employees

Employees93

XFOR Key Statistics

Market cap

51.32M

Market cap51.32M

Price-Earnings ratio

-3.45

Price-Earnings ratio-3.45

Dividend yield

—

Dividend yield—

Average volume

1.44M

Average volume1.44M

High today

$0.3072

High today$0.3072

Low today

$0.2901

Low today$0.2901

Open price

$0.31

Open price$0.31

Volume

138.00K

Volume138.00K

52 Week high

$1.60

52 Week high$1.60

52 Week low

$0.2612

52 Week low$0.2612

X4 Pharmaceuticals

Why Robinhood?

X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor. Show more

XFOR Key Statistics

X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor.